Journal of Clinical Investigation - JCI INSIGHT: JAK inhibitors reverse hair loss in alopecia areata There are few treatments available to prevent and reverse hair loss associated with alopecia areata, a common
![Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients | Semantic Scholar Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/04339364fc49b7c4a495af383707809cd97f0686/2-Figure1-1.png)
Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients | Semantic Scholar
![Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment | SMJ Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment | SMJ](http://www.smj.org.sg/sites/default/files/SMJ-58-279-g001.jpg)
Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment | SMJ
![Frontiers | Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib Frontiers | Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib](https://www.frontiersin.org/files/Articles/654376/fimmu-12-654376-HTML-r1/image_m/fimmu-12-654376-g001.jpg)
Frontiers | Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
![Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study - Bokhari - 2018 - International Journal of Dermatology - Wiley Online Library Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study - Bokhari - 2018 - International Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/83d90fee-4422-4fc1-b520-cdf2d52cc57e/ijd14192-fig-0005-m.jpg)
Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study - Bokhari - 2018 - International Journal of Dermatology - Wiley Online Library
![Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib - eBioMedicine Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib - eBioMedicine](https://www.thelancet.com/cms/asset/43327719-6a33-431f-b355-9c5caf7dcc6a/gr1.jpg)
Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib - eBioMedicine
![Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus | Annals of the Rheumatic Diseases Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/79/5/674/F1.large.jpg)